LBA5 A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA)
| Autor: | Powles, T.B., van der Heijden, M.S., Galsky, M.D., Al-Ahmadie, H., Meeks, J.J., Nishiyama, H., Vu, T.Q., Antonuzzo, L., Wiechno, P., Atduev, V., Kann, A.G., Kim, T-H., Suarez Rodriguez, C., Chang, C-H., Roghmann, F., Ozguroglu, M., Armstrong, J., Ho, S., Hois, S., Catto, J. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1271-S1271 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|